Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

TWOU
2U Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $34.889 $137.438 $73.399 $53.851
Short term investments
Net receivables $95.157 $91.431 $144.237 $142.398
Inventory
Total current assets $164.858 $259.39 $251.464 $233.971
Long term investments
Property, plant & equipment $89.124 $99.791 $104.219 $107.679
Goodwill & intangible assets $605.537 $1,007.086 $1,022.696 $1,098.916
Total noncurrent assets $759.456 $1,173.547 $1,208.219 $1,303.964
Total investments
Total assets $924.314 $1,432.937 $1,459.683 $1,537.935
Current liabilities
Accounts payable $73.186 $114 $103.378 $128.316
Deferred revenue $83.781 $102.286 $81.949 $116.276
Short long term debt $922.063 $14.472 $15.158 $15.106
Total current liabilities $1,122.847 $284.765 $259.339 $314.634
Long term debt $77.248 $978.14 $979.811 $964.505
Total noncurrent liabilities $78.678 $979.594 $981.299 $966.822
Total debt $999.311 $992.612 $994.969 $979.611
Total liabilities $1,201.525 $1,264.359 $1,240.638 $1,281.456
Stockholders' equity
Retained earnings -$2,004.668 -$1,552.228 -$1,497.579 -$1,455.131
Other stockholder equity -$24.656 -$26.807 -$25.116 -$26.564
Total stockholder equity -$277.211 $168.578 $219.045 $256.479
(in millions USD) 2023 2022 2021
Current assets
Cash $73.399 $182.578 $249.909
Short term investments
Net receivables $144.237 $96.639 $96.726
Inventory
Total current assets $251.464 $322.307 $393.852
Long term investments
Property, plant & equipment $104.219 $118.216 $125.491
Goodwill & intangible assets $1,022.696 $1,284.375 $1,500.062
Total noncurrent assets $1,208.219 $1,488.552 $1,715.154
Total investments
Total assets $1,459.683 $1,810.859 $2,109.006
Current liabilities
Accounts payable $103.378 $110.02 $166.458
Deferred revenue $81.949 $90.161 $91.926
Short long term debt $15.158 $13.909 $13.985
Total current liabilities $259.339 $278.992 $333.507
Long term debt $979.811 $1,028.273 $943.982
Total noncurrent liabilities $981.299 $1,030.351 $946.344
Total debt $994.969 $1,042.182 $957.967
Total liabilities $1,240.638 $1,309.343 $1,279.851
Stockholders' equity
Retained earnings -$1,497.579 -$1,179.972 -$890.638
Other stockholder equity -$25.116 -$19.445 -$15.911
Total stockholder equity $219.045 $501.516 $829.155

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $180.683 $198.377 $255.661 $229.699
Cost of revenue $52.353 $56.563 $57.339 $63.627
Gross profit $128.33 $141.814 $198.322 $166.072
Operating activities
Research & development $32.062 $34.995 $40.607 $45.877
Selling, general & administrative $123.753 $129.414 $103.788 $133.057
Total operating expenses $560.37 $169.136 $220.823 $193.019
Operating income -$432.04 -$27.322 -$22.501 -$26.947
Income from continuing operations
EBIT -$433.104 -$35.149 -$21.691 -$28.169
Income tax expense -$0.04 $0.233 $1.224 $0.107
Interest expense $19.376 $19.267 $19.533 $19.167
Net income
Net income -$452.44 -$54.649 -$42.448 -$47.443
Income (for common shares) -$452.44 -$54.649 -$42.448 -$47.443
(in millions USD) 2023 2022 2021
Revenue
Total revenue $945.953 $963.08 $945.682
Cost of revenue $257.602 $277.683 $269.365
Gross profit $688.351 $685.397 $676.317
Operating activities
Research & development $176.218 $190.472 $179.061
Selling, general & administrative $504.809 $581.565 $664.694
Total operating expenses $914.154 $943.567 $843.755
Operating income -$225.803 -$258.17 -$167.438
Income from continuing operations
EBIT -$241.38 -$260.82 -$144.74
Income tax expense $1.654 -$0.903 -$1.196
Interest expense $74.573 $62.234 $51.222
Net income
Net income -$317.607 -$322.151 -$194.766
Income (for common shares) -$317.607 -$322.151 -$194.766

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$452.44 -$54.649 -$42.448 -$47.443
Operating activities
Depreciation $29.037 $28.848 $32.716 $33.858
Business acquisitions & disposals $0.1
Stock-based compensation $4.511 $5.324 $3.702 $10.44
Total cash flows from operations -$92.174 $72.249 $14.089 -$18.702
Investing activities
Capital expenditures -$0.289 -$0.176 -$1.686 -$2.23
Investments
Total cash flows from investing -$8.398 -$7.31 -$13.255 -$11.544
Financing activities
Dividends paid
Sale and purchase of stock $0.661
Net borrowings -$1.112 -$1.376 $18.631 $18.619
Total cash flows from financing -$1.123 -$0.827 $18.495 $18.398
Effect of exchange rate -$0.854 -$0.073 $0.219 -$1
Change in cash and equivalents -$102.549 $64.039 $19.548 -$12.848
(in millions USD) 2023 2022 2021
Net income -$317.607 -$322.151 -$194.766
Operating activities
Depreciation $132.726 $149.173 $127.381
Business acquisitions & disposals $0.2 $4.9 -$760.918
Stock-based compensation $39.688 $80.22 $97.766
Total cash flows from operations -$3.431 $10.927 -$18.074
Investing activities
Capital expenditures -$6.021 -$11.755 -$9.788
Investments $37.818
Total cash flows from investing -$49.831 -$69.35 -$793.434
Financing activities
Dividends paid
Sale and purchase of stock $2.212 $2.41 $10.072
Net borrowings -$56.137 -$6.485 $553.568
Total cash flows from financing -$55.018 -$6.925 $544.86
Effect of exchange rate -$0.899 -$1.983 -$2.309
Change in cash and equivalents -$109.179 -$67.331 -$268.957

ACHC
Acadia Healthcare Company Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $77.167 $77.303 $100.073 $99.591
Short term investments
Net receivables $389.374 $386.191 $361.451 $362.666
Inventory
Total current assets $645.214 $610.806 $596 $703.475
Long term investments
Property, plant & equipment $2,621.129 $2,497.405 $2,384.39 $2,267.689
Goodwill & intangible assets $2,334.743 $2,334.378 $2,299.24 $2,299.773
Total noncurrent assets $5,032.838 $4,906.441 $4,762.841 $4,642.743
Total investments
Total assets $5,678.052 $5,517.247 $5,358.841 $5,346.218
Current liabilities
Accounts payable $159.52 $156.13 $156.132 $149.874
Deferred revenue
Short long term debt $93.584 $88.267 $55.487 $52.805
Total current liabilities $546.522 $482.313 $885.781 $864.89
Long term debt $1,879.262 $1,897.648 $1,443.356 $1,454.827
Total noncurrent liabilities $2,066.934 $2,059.579 $1,585.4 $1,671.184
Total debt $1,972.846 $1,985.915 $1,498.843 $1,507.632
Total liabilities $2,613.456 $2,541.892 $2,471.181 $2,536.074
Stockholders' equity
Retained earnings $286.586 $208.104 $131.721 $73.992
Other stockholder equity
Total stockholder equity $2,952.718 $2,866.022 $2,781.974 $2,712.562
(in millions USD) 2023 2022 2021
Current assets
Cash $100.073 $97.649 $133.813
Short term investments
Net receivables $361.451 $322.439 $281.332
Inventory
Total current assets $596 $506.125 $495.031
Long term investments
Property, plant & equipment $2,384.39 $2,087.283 $1,904.92
Goodwill & intangible assets $2,299.24 $2,298.846 $2,270.082
Total noncurrent assets $4,762.841 $4,481.776 $4,273.047
Total investments
Total assets $5,358.841 $4,987.901 $4,768.078
Current liabilities
Accounts payable $156.132 $104.723 $98.575
Deferred revenue
Short long term debt $55.487 $47.713 $41.942
Total current liabilities $885.781 $388.326 $404.861
Long term debt $1,443.356 $1,480.97 $1,595.467
Total noncurrent liabilities $1,585.4 $1,698.591 $1,780.34
Total debt $1,498.843 $1,528.683 $1,637.409
Total liabilities $2,471.181 $2,086.917 $2,185.201
Stockholders' equity
Retained earnings $131.721 $153.388 -$119.751
Other stockholder equity
Total stockholder equity $2,781.974 $2,812.727 $2,517.489

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $796.04 $768.051 $742.8 $750.334
Cost of revenue $507.574 $501.726 $484.267 $478.568
Gross profit $288.466 $266.325 $258.533 $271.766
Operating activities
Research & development
Selling, general & administrative $109.69 $101.073 $98.108 $104.048
Total operating expenses $152.847 $140.267 $167.841 $538.422
Operating income $135.619 $126.058 $90.692 -$266.656
Income from continuing operations
EBIT $133.284 $123.671 $98.411 -$268.841
Income tax expense $25.643 $20.074 $20.208 -$71.873
Interest expense $29.159 $27.214 $20.474 $20.742
Net income
Net income $78.482 $76.383 $57.729 -$217.71
Income (for common shares) $78.482 $76.383 $57.729 -$217.71
(in millions USD) 2023 2022 2021
Revenue
Total revenue $2,928.738 $2,610.399 $2,314.394
Cost of revenue $1,900.887 $1,697.109 $1,509.764
Gross profit $1,027.851 $913.29 $804.63
Operating activities
Research & development
Selling, general & administrative $388.906 $349.277 $301.339
Total operating expenses $980.833 $469.387 $427.227
Operating income $47.018 $443.903 $377.403
Income from continuing operations
EBIT $50.759 $437.009 $335.185
Income tax expense -$9.699 $94.11 $67.557
Interest expense $82.125 $69.76 $76.993
Net income
Net income -$21.667 $273.139 $190.635
Income (for common shares) -$21.667 $273.139 $190.635

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $78.482 $76.383 $57.729 -$217.71
Operating activities
Depreciation $36.066 $36.347 $35.38 $33.388
Business acquisitions & disposals -$0.369 -$50.353 -$0.349
Stock-based compensation $8.869 $8.678 $9.149 $8.163
Total cash flows from operations $171.148 -$321.285 $116.304 $137.858
Investing activities
Capital expenditures -$153.089 -$133.354 -$109.934 -$128.039
Investments
Total cash flows from investing -$155.484 -$184.614 -$110.168 -$129.373
Financing activities
Dividends paid
Sale and purchase of stock -$0.655 -$1.013 $0.858 $0.711
Net borrowings -$15.363 $483.24 -$5.312 -$20.313
Total cash flows from financing -$15.8 $483.129 -$5.654 -$21.067
Effect of exchange rate
Change in cash and equivalents -$0.136 -$22.77 $0.482 -$12.582
(in millions USD) 2023 2022 2021
Net income -$21.667 $273.139 $190.635
Operating activities
Depreciation $132.349 $117.769 $106.717
Business acquisitions & disposals -$0.349 -$9.507 $1,372.005
Stock-based compensation $32.289 $29.635 $37.53
Total cash flows from operations $462.34 $380.569 $374.477
Investing activities
Capital expenditures -$394.711 -$289.075 -$272.719
Investments -$84.795
Total cash flows from investing -$397.219 -$305.83 $1,017.633
Financing activities
Dividends paid
Sale and purchase of stock -$44.335 -$6.179
Net borrowings -$16.25 -$113.594 -$1,648.868
Total cash flows from financing -$62.697 -$110.903 -$1,641.061
Effect of exchange rate $4.067
Change in cash and equivalents $2.424 -$36.164 -$244.884

AEIS
Advanced Energy Industries Inc.
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $986.148 $1,017.78 $1,044.556 $985.931
Short term investments
Net receivables $262.419 $247.51 $282.43 $270.348
Inventory $383.141 $361.337 $336.137 $364.003
Total current assets $1,677.839 $1,671.617 $1,711.894 $1,673.473
Long term investments
Property, plant & equipment $284.146 $281.62 $263.097 $260.262
Goodwill & intangible assets $449.092 $435.224 $445.318 $449.924
Total noncurrent assets $864.02 $852.471 $844.863 $820.213
Total investments
Total assets $2,541.859 $2,524.088 $2,556.757 $2,493.686
Current liabilities
Accounts payable $157.523 $137.934 $141.85 $140.32
Deferred revenue
Short long term debt $36.299 $37.049 $37.744 $37.477
Total current liabilities $306.837 $297.992 $335.848 $314.812
Long term debt $984.56 $991.348 $985.009 $989.637
Total noncurrent liabilities $1,069.946 $1,083.213 $1,076.727 $1,078.003
Total debt $1,020.859 $1,028.397 $1,022.753 $1,027.114
Total liabilities $1,376.783 $1,381.205 $1,412.575 $1,392.815
Stockholders' equity
Retained earnings $1,002.175 $991.058 $989.731 $956.161
Other stockholder equity -$6.823 -$1.855 $6.114 $5.39
Total stockholder equity $1,165.076 $1,142.883 $1,144.182 $1,100.871
(in millions USD) 2023 2022 2021
Current assets
Cash $1,044.556 $458.818 $544.372
Short term investments $2.296
Net receivables $282.43 $300.683 $237.227
Inventory $336.137 $376.012 $338.41
Total current assets $1,711.894 $1,188.514 $1,162.234
Long term investments
Property, plant & equipment $263.097 $248.639 $216.599
Goodwill & intangible assets $445.318 $470.959 $371.596
Total noncurrent assets $844.863 $803.654 $655.106
Total investments $2.296
Total assets $2,556.757 $1,992.168 $1,817.34
Current liabilities
Accounts payable $141.85 $170.467 $193.708
Deferred revenue $6.2
Short long term debt $37.744 $36.771 $35.843
Total current liabilities $335.848 $393.043 $370.196
Long term debt $985.009 $447.722 $467.913
Total noncurrent liabilities $1,076.727 $532.858 $575.648
Total debt $1,022.753 $484.493 $503.756
Total liabilities $1,412.575 $925.901 $945.844
Stockholders' equity
Retained earnings $989.731 $915.27 $756.323
Other stockholder equity $6.114 $16.32 -$1.216
Total stockholder equity $1,144.182 $1,066.267 $870.851

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $364.947 $327.475 $405.271 $409.991
Cost of revenue $237.206 $214.646 $262.405 $262.65
Gross profit $127.741 $112.829 $142.866 $147.341
Operating activities
Research & development $52.335 $49.836 $49.025 $50.391
Selling, general & administrative $55.013 $55.124 $54.932 $55.131
Total operating expenses $114.773 $112.152 $129.096 $117.28
Operating income $12.968 $0.677 $13.77 $30.061
Income from continuing operations
EBIT $25.15 $14.13 $32.375 $33.595
Income tax expense $3.165 $1.787 -$21.693 $0.874
Interest expense $6.956 $7.127 $16.566
Net income
Net income $15.029 $5.216 $37.502 $32.721
Income (for common shares) $15.029 $5.216 $37.502 $32.721
(in millions USD) 2023 2022 2021
Revenue
Total revenue $1,655.81 $1,845.422 $1,455.954
Cost of revenue $1,063.412 $1,169.916 $923.632
Gross profit $592.398 $675.506 $532.322
Operating activities
Research & development $202.439 $191.02 $161.831
Selling, general & administrative $221.034 $218.463 $191.998
Total operating expenses $478.704 $442.411 $380.641
Operating income $113.694 $233.095 $151.681
Income from continuing operations
EBIT $136.562 $239.51 $148.74
Income tax expense -$8.288 $39.85 $14.004
Interest expense $16.566
Net income
Net income $128.284 $199.66 $134.736
Income (for common shares) $128.284 $199.66 $134.736

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $15.029 $5.216 $37.502 $32.721
Operating activities
Depreciation $16.966 $16.952 $16.769 $16.798
Business acquisitions & disposals -$13.762
Stock-based compensation $11.384 $11.005 $8.188 $8.075
Total cash flows from operations $6.714 $7.283 $84.004 $72.519
Investing activities
Capital expenditures -$14.777 -$16.629 -$14.223 -$13.159
Investments -$0.309 -$2.092 -$0.299 -$0.319
Total cash flows from investing -$28.848 -$18.721 -$14.522 -$13.478
Financing activities
Dividends paid -$3.848 -$3.81 -$3.8 -$3.83
Sale and purchase of stock -$0.173 -$5.327 $1.175 $34.995
Net borrowings -$5 -$5 -$5.895 $442.015
Total cash flows from financing -$9.021 -$14.137 -$8.52 $473.18
Effect of exchange rate -$0.477 -$1.201 -$2.337 -$1.542
Change in cash and equivalents -$31.632 -$26.776 $58.625 $530.679
(in millions USD) 2023 2022 2021
Net income $128.284 $199.66 $134.736
Operating activities
Depreciation $66.533 $60.296 $52.893
Business acquisitions & disposals -$149.387 -$21.535
Stock-based compensation $31.001 $19.849 $15.739
Total cash flows from operations $208.937 $183.587 $140.245
Investing activities
Capital expenditures -$61.005 -$58.885 -$28.817
Investments -$3.746 $3.05
Total cash flows from investing -$64.751 -$208.272 -$47.302
Financing activities
Dividends paid -$15.222 -$15.204 -$15.385
Sale and purchase of stock $34.786 -$26.661 -$79.887
Net borrowings $426.12 -$20 $69.9
Total cash flows from financing $445.684 -$61.865 -$25.372
Effect of exchange rate -$4.132 $0.996 -$3.567
Change in cash and equivalents $585.738 -$85.554 $64.004

AERI
Aerie Pharmaceuticals Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $54.093 $39.442 $56.441 $37.187
Short term investments $118.371 $144.93 $138.807 $102.614
Net receivables $73.881 $68.081 $63.617 $158.828
Inventory $46.762 $47.007 $40.19 $40.41
Total current assets $302.813 $311.41 $316.966 $355.65
Long term investments $3.985
Property, plant & equipment $71.056 $72.389 $73.142 $74.141
Goodwill & intangible assets
Total noncurrent assets $72.777 $73.93 $78.58 $75.741
Total investments $118.371 $144.93 $142.792 $102.614
Total assets $375.59 $385.34 $395.546 $431.391
Current liabilities
Accounts payable $9.062 $9.279 $7.877 $8.285
Deferred revenue $70.881 $70.438 $70 $64.315
Short long term debt $4.873 $4.744 $4.464 $4.365
Total current liabilities $133.333 $119.662 $115.291 $124.991
Long term debt $332.113 $332.55 $332.711 $256.278
Total noncurrent liabilities $406.239 $406.812 $405.967 $323.733
Total debt $336.986 $337.294 $337.175 $260.643
Total liabilities $539.572 $526.474 $521.258 $448.724
Stockholders' equity
Retained earnings -$1,188.037 -$1,161.211 -$1,141.84 -$1,153.911
Other stockholder equity -$0.803 -$0.793 -$0.43 -$0.126
Total stockholder equity -$163.982 -$141.134 -$125.712 -$17.333
(in millions USD) 2021 2020 2019
Current assets
Cash $37.187 $151.57 $143.94
Short term investments $102.614 $88.794 $165.25
Net receivables $158.828 $56.022 $38.354
Inventory $40.41 $27.059 $21.054
Total current assets $355.65 $331.755 $376.342
Long term investments
Property, plant & equipment $74.141 $68.344 $74.67
Goodwill & intangible assets
Total noncurrent assets $75.741 $70.29 $76.266
Total investments $102.614 $88.794 $165.25
Total assets $431.391 $402.045 $452.608
Current liabilities
Accounts payable $8.285 $8.826 $12.77
Deferred revenue $64.315 $50.858
Short long term debt $4.365 $4.923 $5.502
Total current liabilities $124.991 $104.472 $83.648
Long term debt $256.278 $220.579 $200.753
Total noncurrent liabilities $323.733 $273.605 $202.01
Total debt $260.643 $225.502 $206.255
Total liabilities $448.724 $378.077 $285.658
Stockholders' equity
Retained earnings -$1,153.911 -$1,079.101 -$896
Other stockholder equity -$0.126 -$0.052 -$0.092
Total stockholder equity -$17.333 $23.968 $166.95

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $36.129 $33.311 $29.835 $114.666
Cost of revenue $6.929 $3.741 $6.78 $6.07
Gross profit $29.2 $29.57 $23.055 $108.596
Operating activities
Research & development $21.994 $19.558 $25.174 $20.847
Selling, general & administrative $33.878 $28.149 $31.524 $36.009
Total operating expenses $55.872 $47.707 $56.698 $56.856
Operating income -$26.672 -$18.137 -$33.643 $51.74
Income from continuing operations
EBIT -$26.731 -$19.323 -$35.198 $46.019
Income tax expense $0.095 $0.048 $0.693 $0.486
Interest expense
Net income
Net income -$26.826 -$19.371 -$35.891 $45.533
Income (for common shares) -$26.826 -$19.371 -$35.891 $45.533
(in millions USD) 2021 2020 2019
Revenue
Total revenue $194.134 $83.138 $69.888
Cost of revenue $26.846 $25.333 $4.833
Gross profit $167.288 $57.805 $65.055
Operating activities
Research & development $75.837 $74.007 $91.378
Selling, general & administrative $137.805 $137.184 $138.402
Total operating expenses $213.642 $213.495 $252.547
Operating income -$46.354 -$155.69 -$187.492
Income from continuing operations
EBIT -$74.217 -$177.856 -$199.671
Income tax expense $0.593 $5.245 -$0.09
Interest expense
Net income
Net income -$74.81 -$183.101 -$199.581
Income (for common shares) -$74.81 -$183.101 -$199.581

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$26.826 -$19.371 -$35.891 $45.533
Operating activities
Depreciation $3.348 $3.425 $3.611 $9.783
Business acquisitions & disposals
Stock-based compensation $3.642 $3.958 $4.632 $6.166
Total cash flows from operations -$11.401 -$13.233 $61.911 -$30.11
Investing activities
Capital expenditures -$0.813 -$1.369 -$1.597 -$0.751
Investments $26.677 -$2.563 -$40.703 $2.814
Total cash flows from investing $25.864 -$3.932 -$42.3 $2.063
Financing activities
Dividends paid
Sale and purchase of stock $0.188 $0.166 -$0.357 $3.387
Net borrowings
Total cash flows from financing $0.188 $0.166 -$0.357 $3.387
Effect of exchange rate
Change in cash and equivalents $14.651 -$16.999 $19.254 -$24.66
(in millions USD) 2021 2020 2019
Net income -$74.81 -$183.101 -$199.581
Operating activities
Depreciation $37.5 $34.158 $18.114
Business acquisitions & disposals -$7.835
Stock-based compensation $29.524 $40.095 $45.093
Total cash flows from operations -$99.154 -$64.69 -$150.43
Investing activities
Capital expenditures -$3.291 -$3.1 -$9.958
Investments -$14.91 $76.279 -$165.454
Total cash flows from investing -$18.201 $73.179 -$183.247
Financing activities
Dividends paid
Sale and purchase of stock $2.972 $0.761
Net borrowings $308.349
Total cash flows from financing $2.972 -$0.859 $274.799
Effect of exchange rate
Change in cash and equivalents -$114.383 $7.63 -$58.878